Evonik and Sabo conclude sale of TAA derivatives business
With the sale of its TAA derivatives business to SABO, Evonik is taking the next step in focusing its portfolio on specialty chemicals. ... MORE
With the sale of its TAA derivatives business to SABO, Evonik is taking the next step in focusing its portfolio on specialty chemicals. ... MORE
... MORE
... MORE
... MORE
... MORE
Evonik has invested in the biopharmaceutical company Allay Therapeutics. The U.S.- and Singapore-based startup has developed an implant for treating pain after knee surgery. ... MORE